Silexion Therapeutics Corp (SLXN) AI Dilution Summary

Cash was $2,229,000 at 2026-06-30 against estimated monthly burn of $975,000. The most recent capital raised was a registered public offering closed 2026-08-13: 2,028,619 shares at $0.6500, for gross proceeds of $2,499,822.90 and net proceeds of $2,100,000. Dilution here is driven primarily by the H.C. Wainwright ATM program.